Earth Science Tech, Inc.

Earth Science Tech, Inc. is a U.S.-based healthcare and wellness company operating through subsidiaries including Peaks, DOC, Villas, RxCompoundstore, Avenvi, and Mister Meds. Its business spans telehealth, pharmacy/compounding, and related wellness offerings, with revenue driven by customer acquisition, brand building, and the ability to keep patients engaged across a fast-changing digital health market.

71,4 %

10,2 %

+7,8 %

1.93

1.58

— Earth Science Tech, Inc.
%
Telehealth services45% Virtual healthcare offerings delivered through the company's telehealth brands and provider network.
Pharmacy and compounding30% Prescription fulfillment and compounded medication services handled through pharmacy operations.
Wellness and related services15% Consumer-facing wellness and condition-focused offerings marketed through the platform.
Marketing and customer acquisition10% Digital marketing, influencer, and brand-led demand generation that supports customer growth.

The company serves consumers seeking telehealth, pharmacy, and wellness solutions, with demand driven by convenience,...

  • Telehealth patientsprimary

    Patients using Peaks, DOC, and Villas for virtual consultations and ongoing care.

  • Pharmacy customersprimary

    Customers filling prescriptions or compounded medications through RxCompound and Mister Meds.

  • Wellness consumerssecondary

    Consumers buying wellness-related offerings marketed through the company's brands and social channels.

  • Condition-specific care userssecondary

    Patients seeking treatment for specific conditions available through the platform's provider network.

The company is headquartered in the United States and its disclosed operations are centered there...

  • United States is the core operating and customer market
  • Inventory is stored at facilities in Miami, Florida and Abilene, Texas
  • U.S. healthcare and marketing regulation directly affects operations
  • No country-level revenue disclosure was provided in the excerpts

Management is focused on expanding the scope of offerings, growing the number and quality of healthcare providers, and...

01
Broaden the offering setmedium-term

More products, services, and treatable conditions can increase customer lifetime value and market reach.

02
Improve customer acquisition and retentionshort-term

Revenue depends on marketing effectiveness, platform engagement, and repeat usage.

03
Protect operating continuityshort-term

Centralized inventory and affiliated-provider operations create service and reputational risk if disrupted.

The business is exposed to customer acquisition risk, regulatory risk, and brand/reputation risk because its model...

high

Customer acquisition and retention failure

The company says growth depends on marketing and platform engagement; weak demand generation would hurt revenue.

Scope
Telehealth and wellness customer funnel
Materiality
high
high

Healthcare, privacy, and advertising regulation

Changes in laws can restrict outreach, increase compliance costs, or trigger penalties.

Scope
Digital marketing, telehealth, pharmacy operations
Materiality
high
high

Brand and reputational damage

The company relies heavily on brand strength and social/influencer marketing, which can backfire if misused.

Scope
Consumer-facing healthcare brands
Materiality
high
high

Centralized inventory disruption

Inventory is housed at two facilities; damage or interruption could impair order fulfillment.

Scope
Miami, Florida and Abilene, Texas facilities
Materiality
medium
medium

Competition from larger healthcare and pharmacy companies

Better-capitalized rivals may outspend the company on marketing, technology, and provider networks.

Scope
Telehealth, pharmacy, and wellness markets
Materiality
high
Revenue recognition timing
Can shift revenue between periods depending on fulfillment terms
Goodwill impairment
Potential non-cash charges to earnings
Fair value of equity securities
Can create volatility in net income
Estimates and contingencies
Affects reserves, depreciation/amortization, and reported risk profile

: 28/04/2026